Skip to content
NEWSR
Digital Safety · 5 min read

What Manulife Asia’s AI Award Actually Tells Policyholders and Insurers

Manulife Asia’s 2026 AI award signals broad deployment across insurance operations, but the public evidence still leaves customer outcomes, privacy and reliability questions open.

Jordan Ellis
In this story
Editorial illustration of AI-assisted life and health insurance workflows

Key takeaways

  • Manulife Asia won the Best Overall AI Adoption: Life/Health award at the 2026 Asia Consumer Insurance Awards.
  • The company says AI is used across claims, underwriting support, customer service, distribution, investment research and productivity.
  • Reported AI-value figures and adoption rates are company disclosures, not independent tests of customer outcomes.
  • The main unresolved issues are decision accuracy, privacy, human review, reliability and whether savings reach policyholders.
  • The next useful signal is detailed reporting on outcomes and the company’s 2027 AI-value target.

Bottom line: Manulife Asia’s 2026 AI award is useful evidence that artificial intelligence has moved beyond pilot projects inside a large insurer, but it is not proof that policyholders will automatically receive cheaper, fairer or more reliable service. The public material describes broad deployment and company-reported value; it does not independently establish the quality of individual decisions.

The verified event is an industry award, not a performance audit

Manulife Asia was named the winner of the Best Overall AI Adoption: Life/Health award at the 2026 Asia Consumer Insurance Awards, organized by (Re)Insurance Asia. The announcement was published on Aug. 18, 2026.

The award recognizes life and health insurers that demonstrate broad AI adoption across multiple business functions. That makes the result relevant as a marker of organizational scale. It does not, by itself, measure whether an automated underwriting decision is more accurate than a human decision, whether claims are settled more fairly, or whether customers pay less.

That distinction matters because awards and adoption rankings answer a different question from an operational audit. Manulife’s separate June 2026 announcement said Evident named it the number one life insurer for AI maturity for the second consecutive year and ranked it third overall in the index. Those are additional signals of deployment and strategy, not independent testing of every system named by the company.

What Manulife says it is using AI to do

According to the award announcement, Manulife’s initiatives in Asia include customer and distribution assistants, claims triage, document processing, underwriting support, investment research tools and productivity software including Microsoft Copilot and proprietary tools. The company also describes AI-enabled capabilities in digital underwriting, claims management and tools for distribution partners.

The practical pattern is important: the insurer is applying AI to workflows that sit between a customer and a final insurance outcome. Some tools may help organize documents or draft responses. Others can influence how applications, claims or investment information are handled. Those uses carry different risks and should not be treated as one category.

Manulife reported 5.2 million AI prompts in Asia during 2025 and said 80% of Asia colleagues were actively using AI tools as of June 2026. The company also reported that it had delivered approximately C$300 million in cumulative AI enterprise value as of Dec. 31, 2025, and expects more than $1 billion in AI enterprise value by 2027.

These figures are company disclosures. The announcement says the expected value can include expense reductions, revenue uplift from AI-powered workflows, fraud reduction and growth absorption. They do not show how much value came from each use case or how benefits and costs are distributed among customers, employees, advisers and shareholders.

The reader’s practical decision: speed is not the same as reliability

For policyholders, the most visible possible benefit is faster service. Automated document processing or claims triage could reduce manual handling, while adviser assistants could shorten the time needed to answer routine questions. But a faster process can also move an error through the system more quickly if records are incomplete or a recommendation is poorly explained.

Anyone dealing with an application, claim or policy change should still ask which decision is automated, what information was used, and how to request human review. The supplied evidence does not say that customers can always obtain those details, so this is a prudent question rather than a confirmed Manulife feature.

Privacy is another unresolved issue. The announcements identify several business functions but do not specify, in the supplied material, what personal or health data is used to train or operate each system, how long it is retained, or which vendors can access it. A customer should not infer from an AI label that a service has a particular privacy standard.

What insurers should prove next

For the insurance industry, Manulife’s disclosures offer a playbook: combine common platforms with local teams, provide role-based training, and assign governance responsibilities through cross-functional delivery and AI Champions. That may help an organization scale tools instead of leaving them as isolated experiments.

The harder test is evidence at the outcome level. Useful future disclosures would separate productivity gains from revenue effects, report error and appeal patterns, explain human oversight, and show whether deployment changes claim handling or underwriting results across markets. They should also clarify where the company’s estimates are realized run-rate savings and where they remain forecasts.

The next milestone is therefore not another adoption announcement alone. It is a measurable account of what these systems do for customers and workers, with enough detail to compare speed against accuracy, efficiency against oversight, and scale against privacy risk. Until that evidence appears, the award supports a claim about adoption—not a blanket claim that AI has improved insurance for everyone.

Newsr Reframed

Manulife Asia’s award is best read as a durable adoption signal rather than a verdict on insurance quality. The evidence shows a large insurer applying AI across multiple functions and reporting substantial employee usage and enterprise value. It does not establish that automated systems produce better underwriting, claims or investment decisions, nor does it show how customer data is handled in each workflow. For readers, the practical question is not whether an insurer uses AI, but where it is used, what human review remains, and what measurable outcomes the insurer is willing to disclose.

Sources and methodology

Share this story Facebook X LinkedIn Reddit WhatsApp Email

Latest stories